Pharma-Bio Serv Financials
| PBSV Stock | USD 0.62 0.03 5.08% |
With this module, you can analyze Pharma-Bio financials for your investing period. You should be able to track the changes in Pharma-Bio Serv individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Pharma-Bio |
The data published in Pharma-Bio Serv's official financial statements typically reflect Pharma-Bio Serv's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Pharma-Bio Serv's quantitative information. For example, before you start analyzing numbers published by Pharma-Bio accountants, it's essential to understand Pharma-Bio Serv's liquidity, profitability, and earnings quality within the context of the Life Sciences Tools & Services space in which it operates.
Please note, the imprecision that can be found in Pharma-Bio Serv's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Pharma Bio Serv. Check Pharma-Bio Serv's Beneish M Score to see the likelihood of Pharma-Bio Serv's management manipulating its earnings.
Pharma-Bio Serv Stock Summary
Pharma-Bio Serv competes with CareCloud, Vitalhub Corp, EUDA Health, Aclarion, and Healthcare Triangle. Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico. Pharma Bio operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 190 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | US71711N1000 |
| Business Address | Pharma-Bio Serv Building, |
| Sector | Life Sciences Tools & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.pharmabioserv.com |
| Phone | 787 278 2709 |
| Currency | USD - US Dollar |
Pharma-Bio Serv Key Financial Ratios
There are many critical financial ratios that Pharma-Bio Serv's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Pharma Bio Serv reports annually and quarterly.| Return On Equity | 0.0568 | |||
| Return On Asset | 0.033 | |||
| Target Price | 1.77 | |||
| Number Of Employees | 140 | |||
| Beta | 0.36 |
Pharma-Bio Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pharma-Bio Serv's current stock value. Our valuation model uses many indicators to compare Pharma-Bio Serv value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pharma-Bio Serv competition to find correlations between indicators driving Pharma-Bio Serv's intrinsic value. More Info.Pharma Bio Serv is regarded second in return on equity category among its peers. It also is regarded second in return on asset category among its peers reporting about 0.58 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Pharma Bio Serv is roughly 1.72 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pharma-Bio Serv's earnings, one of the primary drivers of an investment's value.Pharma Bio Serv Systematic Risk
Pharma-Bio Serv's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Pharma-Bio Serv volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Pharma Bio Serv correlated with the market. If Beta is less than 0 Pharma-Bio Serv generally moves in the opposite direction as compared to the market. If Pharma-Bio Serv Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Pharma Bio Serv is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Pharma-Bio Serv is generally in the same direction as the market. If Beta > 1 Pharma-Bio Serv moves generally in the same direction as, but more than the movement of the benchmark.
Pharma-Bio Serv January 31, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Pharma-Bio Serv help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pharma Bio Serv. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pharma Bio Serv based on widely used predictive technical indicators. In general, we focus on analyzing Pharma-Bio OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pharma-Bio Serv's daily price indicators and compare them against related drivers.
| Downside Deviation | 10.97 | |||
| Information Ratio | 0.0339 | |||
| Maximum Drawdown | 47.9 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 16.67 |
Additional Tools for Pharma-Bio OTC Stock Analysis
When running Pharma-Bio Serv's price analysis, check to measure Pharma-Bio Serv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma-Bio Serv is operating at the current time. Most of Pharma-Bio Serv's value examination focuses on studying past and present price action to predict the probability of Pharma-Bio Serv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma-Bio Serv's price. Additionally, you may evaluate how the addition of Pharma-Bio Serv to your portfolios can decrease your overall portfolio volatility.